[Your Name/Affiliation Header]
[Academic/Institution Address]
[Email Address]

May 29, 2026

To the Editors of *npj Digital Medicine*
Springer Nature Group

**Subject: Submission of Original Research Article**

Dear Editor-in-Chief and Editors,

I am pleased to submit our original research article, titled **"Biomarker-Based Discriminative Cancer Risk Analysis with LLM Multi-Agent Explanation Consensus: A Cross-Sectional Population Study Introducing the Explanation Alignment Score (EAS)"**, for consideration for publication in *npj Digital Medicine*.

As clinical artificial intelligence transitions from standalone statistical models to hybrid systems where Large Language Models (LLMs) interpret machine learning (ML) predictions, a critical safety gap has emerged. While deep ensembles or classical classifiers can achieve high discrimination, their mathematical explanation frameworks (such as SHAP or LIME) are notoriously difficult for clinical practitioners to quickly interpret at the point of care. Conversely, while LLM clinical narrative agents can explain risk scores in natural language, they are prone to clinical hallucination and are decoupled from the mathematical features that actually drive the underlying classification model.

To bridge this gap, our study presents two key novel contributions:
1.  **The Explanation Alignment Score (EAS)**: A novel, formally defined, and deterministic metric that quantifies feature-level alignment between LLM natural language clinical explanations and mathematical feature attributions (SHAP/LIME).
2.  **An Automated Clinical Hallucination Scorer**: A reproducible, regex-based algorithm with a $\pm15\%$ relative tolerance threshold that algorithmically measures the frequency of numeric clinical claims in LLM output against the patient's actual biomarker profile—eliminating the need for expensive, non-reproducible manual clinical labeling.

We evaluate these contributions on a cohort of **16,762 patients** from the CDC’s National Health and Nutrition Examination Survey (NHANES) spanning 2013 to 2018, containing 485 self-reported cancer cases (lung, liver, and colorectal). Our baseline cross-validated Gradient Boosting classifier achieves robust discriminative performance (AUROC = 0.724, 95% CI [0.706, 0.744], p < 0.001). 

We then implement a state-of-the-art **5-role multi-agent LLM consensus pipeline** (Biomarker Analyst, Risk Stratifier, Differential Diagnoser, PubMed RAG Evidence Grounder, and Triage Coordinator) and evaluate it on a stratified sample of **100 real patients** using LLaMA 3.3 70B (via Groq). Through a rigorous 4-condition ablation study, we demonstrate that while increasing pipeline complexity and adding RAG significantly reduces numeric clinical hallucinations (from 0.161 down to 0.062), LLM narrative features remain only modestly aligned with ML-attributed features (EAS Jaccard = 0.014). This honest, empirical finding reveals a fundamental divergence between LLM semantic reasoning and ML statistical attribution in clinical AI—a finding of critical interest to the readership of *npj Digital Medicine*.

We chose *npj Digital Medicine* because of its prominent leadership in publishing high-fidelity, open-source clinical machine learning pipelines that combine rigorous technical innovation with honest clinical framing. All code, intermediate data structures, and the complete 41-figure visualization registry have been made fully open-source under the Apache 2.0 license to ensure complete clinical reproducibility.

This manuscript is original work and has not been published or submitted elsewhere. There are no competing financial or non-financial interests to declare. 

Thank you for your time and consideration of our work.

Sincerely,

Kasim Vali  
Lead Researcher and Software Architect  
[Affiliation/Contact Information]
